Top compounds associated with response to TLL2


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib FIMM pan-cancer AAC 0.00061 1
mRNA TG-101348 GDSC1000 pan-cancer AAC 8.7e-05 1
mRNA linifanib GDSC1000 pan-cancer AAC 7.9e-05 1
mRNA SNS-032 CTRPv2 pan-cancer AAC -8.2e-05 1
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -7.9e-05 1
mRNA TKI258 CCLE pan-cancer AAC 3.6e-05 1
Download CSV